EUVIMEDEUVIMED entdecken
Open Access

High-Grade Colorectal Adenocarcinomas With SMAD4 Deficiency

Yasamin Mirzabeigi, Nikunj Shah, Kayla R Schwartz, Jeffrey Duryea, Katiana S Delma, Elizabeth A Montgomery, Julio C Poveda, Oliver G McDonald

Modern Pathology · 2026

DOI: 10.1016/j.modpat.2025.100957 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Modern Pathology, 2026. Verfasst von Yasamin Mirzabeigi und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology and Laboratory Medicine, University of Miami Miller School of Medicine, Miami, Florida. Hauptthemen laut MEDLINE: Smad4 Protein, Colorectal Neoplasms, Adenocarcinoma, Biomarkers, Tumor. Die Arbeit nennt 49 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, National Institutes of Health, University of Miami.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Poor prognosis has been reported for patients with SMAD4 deficient (dSMAD4) colorectal adenocarcinomas (CRCs). However, it remains unclear whether unique tumor morphologies or other advanced disease signatures might stratify those patients. To reappraise this possibility across a homogenous cohort of CRC patients with advanced-stage disease, we leveraged next-generation sequencing data to identify 50 dSMAD4 CRCs at our institution. An equal number of next-generation sequencing-verified SMAD4 proficient (pSMAD4) CRCs were identified in parallel, yielding a control group with similar demographics, clinicopathologic parameters, and background genetic drivers as the dSMAD4 test group. Although both groups progressed to stage IV metastatic disease at high rates (dSMAD4: 90%, pSMAD4: 86%), dSMAD4 CRC specimens were enriched with overtly high-grade (HG) mucinous and nonmucinous histomorphologies (dSMAD4, 44%; pSMAD4, 12%; P = .0007). The HG subset drove poor prognosis in dSMAD4 CRCs, as those patients developed widely metastatic disease (P = .0048) with short overall and progression-free survival (P ≤ .0001). Metastasis of unknown primary was not uncommon for HG dSMAD4 CRCs, posing diagnostic challenges in those instances. However, all dSMAD4 CRCs retained positive immunolabeling for either CDX2 or SATB2 irrespective of grade, thereby aiding diagnosis and distinguishing the HG subset from other HG CRCs that lose these biomarkers. Our reappraisal identifies an underappreciated class of HG dSMAD4 CRCs that progresses rapidly to widely metastatic disease with a dismal prognosis. Although HG morphologies may mask CRC origins, immunohistochemistry retains diagnostic utility for dSMAD4 CRCs.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Smad4 ProteinColorectal NeoplasmsAdenocarcinomaBiomarkers, TumorHumansMaleFemaleAgedMiddle AgedNeoplasm GradingAdultAged, 80 and over

Stichwörter der Autor:innen

DPC4SMAD4colonmetastasisrectum

Substanzen

Smad4 ProteinSMAD4 protein, humanBiomarkers, Tumor

Autor:innen und Institutionen

  • Department of Pathology and Laboratory Medicine, University of Miami Miller School of Medicine, Miami, Florida.
  • Department of Pathology and Laboratory Medicine, University of Miami Miller School of Medicine, Miami, Florida; Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine, Miami, Florida.
  • Department of Pathology and Laboratory Medicine, University of Miami Miller School of Medicine, Miami, Florida; Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine, Miami, Florida. Elect…

Förderung

  • NCI NIH HHS
  • National Institutes of Health
  • University of Miami
  • National Institutes of Health National Cancer Institute

Zitieren

APA

Mirzabeigi, Y., Shah, N., Schwartz, K. R., Duryea, J., Delma, K. S., Montgomery, E. A., Poveda, J. C., & McDonald, O. G. (2026). High-Grade Colorectal Adenocarcinomas With SMAD4 Deficiency. Modern Pathology. https://doi.org/10.1016/j.modpat.2025.100957

Vancouver

Mirzabeigi Y, Shah N, Schwartz KR, Duryea J, Delma KS, Montgomery EA, et al. High-Grade Colorectal Adenocarcinomas With SMAD4 Deficiency. Modern Pathology. 2026. doi:10.1016/j.modpat.2025.100957

BibTeX
@article{Mirzabeigi2026,
  author = {Mirzabeigi, Yasamin and Shah, Nikunj and Schwartz, Kayla R and Duryea, Jeffrey and Delma, Katiana S and Montgomery, Elizabeth A and Poveda, Julio C and McDonald, Oliver G},
  title = {High-Grade Colorectal Adenocarcinomas With SMAD4 Deficiency},
  journal = {Modern Pathology},
  year = {2026},
  doi = {10.1016/j.modpat.2025.100957}
}
Kostenlos starten →